Syntis Bio begins patient dosing in Phase I trial of SYNT-101 for obesity

Syntis Bio has dosed the first patient in the SYNTIETY-1 Phase I/Ib trial of SYNT-101, its investigational once-daily oral ...

4 Free Antivirus Programs Consumer Reports Rates Better Than Windows Defender

Having an antivirus app on Windows is a must. While Windows Defender is certainly an option, Consumer Reports rates these ...
Expats.cz

An inside look at Park Lane International School, preparing students for global futures

Explore the transition from primary to secondary, meet teachers, learn about admissions and more at this Prague School's Open Day.

C4 Therapeutics Maps Accelerated Approval Path for Myeloma Drug Cemsidomide at TD Cowen Conference

C4 Therapeutics (NASDAQ:CCCC) used a presentation at TD Cowen’s 46th Annual Healthcare Conference to outline its near- and mid-term clinical plans, emphasizing its lead multiple myeloma program ...

Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma

Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to withdraw is based on ...
Medscape

Study Identifies Factors Linked to Early Melanoma Recurrence

Several clinicopathologic features beyond tumor thickness and ulceration are associated with recurrence risk in patients with localized stage I-II melanoma.
Center for Strategic and International Studies

$3.7 Billion: Estimated Cost of Epic Fury’s First 100 Hours

Operation Epic Fury costs nearly $900 million per day, driven by the large expenditure of munitions. Because most of this is ...
ET Now on MSN

Top MBA colleges in Delhi NCR 2026: Fees, eligibility criteria and admission details

This article highlights the top MBA colleges in Delhi NCR for 2026, including their fees, eligibility criteria, entrance exams, and admission details. It covers well-known institutes such as Bennett ...